Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Artificial Intelligence (AI)-Driven Retinal Screening Device Market Size And Revenue Outlook Through 2030
The artificial intelligence (AI)-driven retinal screening device market size has experienced significant expansion in recent years. Its value is projected to rise from $1.93 billion in 2025 to $2.18 billion in 2026, at a compound annual growth rate (CAGR) of 13.1%. Historically, this growth has been driven by the greater adoption of artificial intelligence (AI)-enabled ophthalmic diagnostics, a growing incidence of diabetic retinopathy, an elevated demand for early retinal disease detection, the enhanced integration of digital health screening programs, and an escalating healthcare focus on preventive eye care.
The artificial intelligence (AI)-driven retinal screening device market is poised for significant expansion in the coming years, projected to reach $3.54 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 12.9%. This anticipated growth during the forecast period stems from factors such as the increasing adoption of autonomous AI-based screening systems, the wider deployment of point-of-care retinal devices, enhanced government backing for digital eye screening initiatives, the broader incorporation of AI tools in teleophthalmology, and a rising need for quick and affordable retinal assessment solutions. Key trends defining this period involve progress in AI algorithms for interpreting retinal images, novel developments in edge-computing retinal screening devices, technological improvements that enhance image acquisition quality, ongoing research and development into multimodal platforms for detecting eye diseases, and advancements in cloud-based AI screening workflows.
Get A Free Sample Report With In-Depth Market Insights:
Artificial Intelligence (AI)-Driven Retinal Screening Device Market Growth Momentum: What Factors Are Shaping Demand?
The increasing prevalence of diabetes is anticipated to fuel the expansion of the AI-driven retinal screening device market in the coming years. Diabetes, a long-term metabolic condition marked by consistently elevated blood glucose, progressively harms blood vessels, including those in the retina, making it a primary cause of avoidable vision loss globally. The heightened burden of diabetes stems from an aging global population and evolving lifestyles, which have led to increased obesity and reduced physical activity in both developed and developing regions. AI-driven retinal screening devices are crucial for diabetes management by facilitating the early identification of diabetes-related retinal damage, broadening screening availability, and aiding prompt clinical action to avert visual impairment. For example, in April 2025, the International Diabetes Federation, a Belgium-based global health organization, reported that around 589 million adults aged 20–79 were living with diabetes globally in 2024, with forecasts suggesting this figure could reach 853 million by 2050, representing a substantial increase over prior decades. Consequently, the mounting worldwide diabetes burden is propelling the growth of the AI-Driven Retinal Screening Device market.
Artificial Intelligence (AI)-Driven Retinal Screening Device Market Segment Analysis And Revenue Potential
The artificial intelligence (AI)-driven retinal screening device market covered in this report is segmented –
1) By Component: Hardware, Software, Services
2) By Technology: Fundus Image-Based Artificial Intelligence (AI), Optical Coherence Tomography (OCT)-Based Artificial Intelligence (AI), Multi-Modal Artificial Intelligence (AI), Machine Learning (ML), Deep Learning (DL), Natural Language Processing (NLP)
3) By Deployment: Cloud-Based, On-Premise
4) By Application: Diabetic Retinopathy, Age-Related Macular Degeneration, Glaucoma, Cataract, Other Applications
5) By End-User: Hospitals, Ophthalmology Clinics, Mobile Clinics Or Rural Camps, Diagnostic Centers, Research And Academia, Telemedicine Providers
Subsegments:
1) By Hardware: Imaging Devices, Sensor Modules, Display Units, Storage Devices
2) By Software: Image Processing Software, Diagnostic Analysis Software, Data Management Software, Reporting And Visualization Software
3) By Services: Installation And Setup, Maintenance And Support, Training And Education, Consulting Services
Artificial Intelligence (AI)-Driven Retinal Screening Device Market Trends Redefining Industry Growth
Companies operating in the artificial intelligence (AI)-driven retinal screening device market are primarily focusing on developing advanced offerings, such as handheld AI fundus cameras, to enhance accessibility, accelerate diagnostic processes, and facilitate earlier disease detection. These handheld AI fundus cameras are defined as portable imaging devices that utilize artificial intelligence for the automated analysis of retinal images to identify signs of disease. For instance, in May 2024, Optomed USA Inc., a US-based medical technology company, introduced the Optomed Aurora AEYE. This product represents the first FDA-cleared, handheld AI fundus camera specifically for the detection of more than mild diabetic retinopathy. The device integrates automatic, AI-based image analysis to provide immediate screening results at the point of care, thereby enabling clinical decision support without requiring the presence of a specialist. Its battery-operated and highly portable nature is engineered to expand access to vital sight-saving screenings across primary care, endocrinology, and other non-specialist environments.
Artificial Intelligence (AI)-Driven Retinal Screening Device Market Competitive Overview And Top Companies
Major companies operating in the artificial intelligence (AI)-driven retinal screening device market are Carl Zeiss Meditec AG, Topcon Corporation, Canon Medical Systems Corporation, Bosch Healthcare Solutions GmbH, Heidelberg Engineering GmbH, Shenzhen Sibionics Technology Co. Ltd., Digital Diagnostics Inc., Optomed Plc, Optain Health Inc., NIDEK Co. Ltd., Airdoc Technology Co. Ltd., Identifeye Health Ltd., Kowa Company Ltd., RetinaLyze System A/S, EyRIS Pte. Ltd., Eyenuk Inc., EYRIS Pte. Ltd., VUNO Inc., Eyenuk Inc., AEYE Health Inc.
View The Full Artificial Intelligence (AI)-Driven Retinal Screening Device Market Report:
Artificial Intelligence (AI)-Driven Retinal Screening Device Market Leading Geography: Which Region Contributes The Most Revenue?
North America was the largest region in the artificial intelligence (AI)-driven retinal screening device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-driven retinal screening device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
